Abbott Molecular Licenses Affy's CGH Microarray Patents

Affymetrix has licensed a number of patents to Abbott Molecular, a division of Abbott Laboratories, Affy said in a statement last week.

The non-exclusive agreement allows Abbott to manufacture and sell comparative genomic hybridization microarrays, readers, and software for research and diagnostics.

Affymetrix did not disclose details of the license in the statement and declined to comment on the deal. Representatives of Abbott did not return e-mails or phone calls seeking comment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.